• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用西班牙语版SF-36评估健康状况的效用值。SF-6D指数与EQ-5D的有效性]

[Estimating utility values for health status using the Spanish version of the SF-36. Validity of the SF-6D index vs EQ-5D].

作者信息

Rebollo Pablo, Morís Joaquín, Ortega Teresa, Valdés Covadonga, Ortega Francisco

机构信息

BAP Health Outcomes Research, Oviedo, Asturias, Spain.

出版信息

Med Clin (Barc). 2007 Apr 14;128(14):536-7. doi: 10.1157/13101163.

DOI:10.1157/13101163
PMID:17433207
Abstract

BACKGROUND AND OBJECTIVE

A new utility index derived of the SF-36, the SF-6D, was recently developed and has been compared with other utility measures. The objective was to validate this index in the Spanish version of SF-36 with respect to the EQ-5D.

METHOD

1,843 complete measures of the SF-36 and the EQ-5D from 1,283 patients who received a solid organ transplant were collected. SF-6D values were calculated using the model proposed by its creator and without tariff values (not weighted). EQ-5D values were calculated using Spanish visual analog scale tariff (VAS-t), the time-trade off tariff (TTO-t) and also without tariff values (not weighted). Spearman correlation coefficients were calculated between SF-6D and EQ-5D values.

RESULTS

Mean value (standard deviation) of SF-6D was 0.67 (0.15), of VAS-t, 0.69 (0.24) and of TTO-t, 0.70 (0.32). SF-6D values had moderate correlation with VAS-t (r = 0.734) and TTO-t (r = 0.731) (both p < 0.001). The not weighted SF-6D had a high correlation with the weighted version (r = 0.969, p < 0.001), and moderate with the VAS-t (r = 0.754), TTO-t (r = 0.750) and no weighted EQ-5D (r = 0.784) (p < 0.001).

CONCLUSIONS

The SF-6D index derived from the Spanish version of SF-36 seem to be a valid utility index to be used with the SF-36 databases from studies made in Spain.

摘要

背景与目的

一种源自SF-36的新效用指数SF-6D最近被开发出来,并已与其他效用测量方法进行了比较。目的是在SF-36西班牙语版本中相对于EQ-5D对该指数进行验证。

方法

收集了1283例接受实体器官移植患者的1843份完整的SF-36和EQ-5D测量数据。使用其创建者提出的模型且不使用关税值(未加权)计算SF-6D值。使用西班牙视觉模拟量表关税值(VAS-t)、时间权衡关税值(TTO-t)且也不使用关税值(未加权)计算EQ-5D值。计算SF-6D与EQ-5D值之间的斯皮尔曼相关系数。

结果

SF-6D的平均值(标准差)为0.67(0.15),VAS-t为0.69(0.24),TTO-t为0.70(0.32)。SF-6D值与VAS-t(r = 0.734)和TTO-t(r = 0.731)具有中等相关性(两者p < 0.001)。未加权的SF-6D与加权版本具有高度相关性(r = 0.969,p < 0.001),与VAS-t(r = 0.754)、TTO-t(r = 0.750)和未加权的EQ-5D(r = 0.784)具有中等相关性(p < 0.001)。

结论

源自SF-36西班牙语版本的SF-6D指数似乎是一个有效的效用指数,可用于西班牙进行的研究中的SF-36数据库。

相似文献

1
[Estimating utility values for health status using the Spanish version of the SF-36. Validity of the SF-6D index vs EQ-5D].[使用西班牙语版SF-36评估健康状况的效用值。SF-6D指数与EQ-5D的有效性]
Med Clin (Barc). 2007 Apr 14;128(14):536-7. doi: 10.1157/13101163.
2
A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.两种间接效用工具作为术后恢复测量指标的有效性比较。
J Surg Res. 2014 Jul;190(1):79-86. doi: 10.1016/j.jss.2014.02.016. Epub 2014 Feb 15.
3
VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.EQ-5D-3L量表和SF-6D量表在西班牙帕金森病患者样本中的效度验证与比较
Nutr Hosp. 2015 Dec 1;32(6):2808-21. doi: 10.3305/nh.2015.32.6.9765.
4
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.基于普通人群假设偏好对EQ-5D和SF-6D实证效度的调查。
Health Econ. 2005 Nov;14(11):1169-89. doi: 10.1002/hec.1006.
5
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.类风湿关节炎患者使用 EQ-5D 和 SF-6D 偏好型通用量表进行效用测量的比较。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.
6
Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.泰国腹膜透析患者中EQ-5D-5L、视觉模拟评分法(VAS)和SF-6D的比较
Value Health Reg Issues. 2019 May;18:59-64. doi: 10.1016/j.vhri.2018.08.005. Epub 2018 Nov 28.
7
Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.健康抱怨归因于银汞合金填充物的患者中 EQ-5D-5L 和 SF-6D 的有效性和反应度:接受银汞合金去除术的患者的前瞻性队列研究。
Health Qual Life Outcomes. 2021 Apr 17;19(1):125. doi: 10.1186/s12955-021-01762-4.
8
The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.疾病严重程度对慢性心力衰竭 EQ-5D 和 SF-6D 效用差异的影响。
Eur J Health Econ. 2011 Aug;12(4):383-91. doi: 10.1007/s10198-010-0252-4. Epub 2010 May 15.
9
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.用于生成EQ-5D和SF-6D值集的估值方法比较。
J Health Econ. 2006 Mar;25(2):334-46. doi: 10.1016/j.jhealeco.2005.09.003. Epub 2005 Nov 4.
10
Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China.哪种方法在获取乳腺癌患者的健康状态效用值方面更好?来自中国大陆的证据。
Eur J Cancer Care (Engl). 2019 Mar;28(2):e12965. doi: 10.1111/ecc.12965. Epub 2018 Nov 30.

引用本文的文献

1
Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial.纤维肌痛多组分干预与常规护理的成本-效用比较:一项实用随机对照试验。
J Rehabil Med. 2023 Dec 19;55:jrm12361. doi: 10.2340/jrm.v55.12361.
2
Study protocol: a randomised, controlled trial of a nurse navigator program for the management of hepatitis C virus in patients with severe mental disorder.研究方案:一项针对严重精神障碍患者丙型肝炎病毒管理的护士导航计划的随机对照试验。
BMC Nurs. 2022 Apr 20;21(1):92. doi: 10.1186/s12912-022-00870-w.
3
Psychosocial correlates of appointment keeping in immigrant cancer patients.
移民癌症患者预约就诊的社会心理相关因素。
J Psychosoc Oncol. 2015;33(2):107-23. doi: 10.1080/07347332.2014.992084. Epub 2015 Jan 9.
4
Cost-effectiveness analysis of the Spanish renal replacement therapy program.西班牙肾脏替代治疗方案的成本效益分析。
Perit Dial Int. 2012 Mar-Apr;32(2):192-9. doi: 10.3747/pdi.2011.00037. Epub 2011 Sep 30.
5
Validity of the Czech, German, Italian, and Spanish version of the Moorehead-Ardelt II questionnaire in patients with morbid obesity.莫尔黑德-阿代尔特二世问卷捷克语、德语、意大利语和西班牙语版本在病态肥胖患者中的有效性。
Obes Facts. 2009;2 Suppl 1(Suppl 1):57-62. doi: 10.1159/000198262. Epub 2009 Mar 18.